technetium-tc-99m-exametazime and Affective-Disorders--Psychotic

technetium-tc-99m-exametazime has been researched along with Affective-Disorders--Psychotic* in 3 studies

Other Studies

3 other study(ies) available for technetium-tc-99m-exametazime and Affective-Disorders--Psychotic

ArticleYear
Cerebral hypoperfusion in medication resistant, depressed patients assessed by Tc99m HMPAO SPECT.
    Journal of affective disorders, 1996, Dec-16, Volume: 41, Issue:3

    Functional imaging studies generally show decreased cerebral metabolism and perfusion in depressed patients relative to normal controls, although the location of the deficits varies. We used Tc99m HMPAO SPECT to compare cerebral blood flow in medication resistant, depressed patients and a normal control group. HMPAO uptake ratios (adjusted for age) were significantly lower in the depressed patients in the transaxial slices 4 cm and 6 cm above the orbitomeatal line (OML) on the left side. Examining individual regions of interest (corrected for age and multiple testing), we found significantly lower perfusion in the left superior temporal, right parietal and bilateral occipital regions in the patient group. These findings are in limited agreement with previous HMPAO SPECT studies. Methodological differences between studies, particularly variability in adjusting data for age, lead to a divergence in findings. Future research should seek to standardize protocols and data analysis in order to generate comparable results.

    Topics: Adult; Affective Disorders, Psychotic; Aged; Antidepressive Agents; Bipolar Disorder; Brain Mapping; Cerebral Cortex; Depressive Disorder; Dominance, Cerebral; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Oximes; Reference Values; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon

1996
Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum.
    Journal of affective disorders, 1992, Volume: 26, Issue:1

    Forty patients with a major depressive episode were investigated at rest using Single Photon Emission Tomography (SPET or SPECT) with 99mTc-exametazime, an intravenous ligand taken into brain in proportion to regional cerebral blood flow, thereby providing an estimate of regional metabolism. All patients were unipolar and were rated on the Newcastle scale and with the 17-item Hamilton scale. They also completed a range of neuropsychological tests. They were compared with 20 control subjects matched for age, gender, premorbid intelligence and education. The uptake of 99mTc-exametazime was expressed for a range of anatomically defined regions of interest relative to calcarine/occipital cortex. The depressed group showed reduced uptake in the majority of cortical and sub-cortical regions examined, most significantly in temporal, inferior frontal and parietal areas. Unexpectedly, there was a strong positive association between uptake and scores on the Newcastle scale, especially in cingulate areas and frontal cortex. After removing the variance attributable to the Newcastle ratings, however, there emerged the expected negative association between Hamilton scores and anterior tracer uptake. The associations between neuropsychological impairment and regional brain uptake of tracer in part reflected the pattern seen with the Newcastle scale: for example, impairment of memory function correlated with higher uptake into posterior cingulate areas. We propose that depressive illness may be characterised by two processes. One leads to an overall reduction in anterior neocortical function, perhaps related to symptom severity. The other mechanism is manifest as relatively increased function, most notably within cingulate and frontal areas of the cerebral cortex in association with psychotic symptoms. The findings offer new understanding of the brain states underlying depressive illness and a potential focus to subsequent neuropharmacological analysis.

    Topics: Adult; Affective Disorders, Psychotic; Brain; Brain Mapping; Depressive Disorder; Energy Metabolism; Female; Frontal Lobe; Humans; Male; Middle Aged; Neuropsychological Tests; Neurotic Disorders; Organotechnetium Compounds; Oximes; Personality Inventory; Regional Blood Flow; Technetium; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon

1992
[Preliminary results of 99mTc-HMPAO-SPECT studies in endogenous psychoses].
    Nuklearmedizin. Nuclear medicine, 1989, Volume: 28, Issue:3

    18 psychopharmacologically treated patients (7 schizophrenics, 5 schizoaffectives, 6 depressives) were studied using 99mTc-HMPAO-SPECT of the brain. The regional cerebral blood flow was measured in three transversal sections (infra-/supraventricular, ventricular) within 6 regions of interest (ROI) respectively (one frontal, one parietal and one occipital in each hemisphere). Corresponding ROIs of the same section in each hemisphere were compared. In the schizophrenics there was a significantly reduced perfusion in the left frontal region of the infraventricular and ventricular section (p less than 0.02) compared with the data of the depressives. The schizoaffectives took an intermediate place. Since the patients were treated with psychopharmaca, the result must be interpreted cautiously. However, our findings seem to be in accordance with post-mortem-, CT- and PET-studies presented in the literature. Our results suggest that 99mTc-HMPAO-SPECT may be helpful in finding cerebral abnormalities in endogenous psychoses.

    Topics: Adult; Affective Disorders, Psychotic; Brain; Cerebrovascular Circulation; Female; Humans; Male; Middle Aged; Organometallic Compounds; Oximes; Schizophrenia; Technetium; Technetium Tc 99m Exametazime; Tomography, Emission-Computed

1989